Project Grant R61HL186458
Award Date 9/1/26
Completion Date 8/31/27
Dollars Obligated $840K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Orange, CT 06477, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Emma Pendleton Bradley Hospital $175,175 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and implement a digital sleep intervention for preschoolers in foster care. The award funds development, pretesting, and evaluation of Nurturing Sleep, a trauma-informed digital public-health-level sleep intervention administered to foster caregivers of children ages 36–71 months. Aim 1 involves...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $353,776 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 20, 2025. The award funds investigation of place-based factors contributing to sleep health disparities in the United States. The research links nationwide public health surveillance data to neighborhood-level factors using geographic information science to test whether individual-level and place-based factors...
- Federal Project Grant Award Summary New York University School of Medicine received a $254,250 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for August 30, 2027. This research project examines neighborhood context factors and their influence on sleep health disparities among first and second-grade children, primarily Black students in New York City....
- The National Heart, Lung, and Blood Institute awarded the Research Foundation For Mental Hygiene, Inc., operating through its New York State Psychiatric Institute, $261,716 on July 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot a doula-delivered cognitive behavioral therapy for insomnia (CBT-I) intervention for pregnant individuals experiencing prenatal sleep disturbances. The project addresses the gap between evidence-based CBT-I treatment efficacy...
- The National Heart, Lung, and Blood Institute awarded Seattle Children's Hospital $1,736,235 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate sleep health and its relationship to childhood systemic lupus erythematosus (CSLE) symptoms within the sociocultural and neighborhood contexts of affected youth. The research examines associations between sleep health dimensions—including duration, efficiency, regularity, and daytime sleepiness—and CSLE...
- The National Heart Lung and Blood Institute awarded Brigham & Women's Hospital $3.243748 million on September 23, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of ambient lighting in circadian misalignment within a chronic variable sleep deficiency paradigm and its impacts on sleep, cognition, and central oxidative stress. The research examines how irregular sleep schedules—common among U.S. adults accommodating social and work...
- The National Heart Lung and Blood Institute (NHLBI) awarded the University of South Carolina $100,000 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a randomized controlled trial evaluating a prevention-focused behavioral sleep intervention for parents of preschool-aged children. The study will enroll 198 parent-child dyads (children ages 2–4 years with insufficient sleep at baseline and no reported sleep disorder) and randomize them to receive either...
- The National Heart, Lung, and Blood Institute awarded Yale University $313,649 under the Cardiovascular Diseases Research program (CFDA 93.837) on August 15, 2026, to derive and validate a clinical prediction rule identifying febrile children and adolescents with sickle cell disease at low risk for bacteremia. The project addresses overtreatment of febrile children with sickle cell disease in emergency departments. Existing clinical guidelines recommend aggressive evaluation for bacteremia due...
- The National Heart, Lung, and Blood Institute awarded Emory University $100,228 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research examining associations between sleep health, protective factors against psychosocial adversity, and stress-related biomarkers including allostatic load and epigenetic age acceleration. The project analyzes multidimensional sleep health—encompassing regularity, satisfaction, alertness, timing,...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded Boston Children's Hospital $171,600 on September 1, 2026, under CFDA 93.837 (Cardiovascular Diseases Research) to support career development and mentored research in pediatric obstructive sleep apnea diagnostics. The award funds the recipient investigator's training in three areas: predictive modeling and machine learning, advanced physiological signal analysis, and implementation science for translating research into clinical...